Allmed Solutions EBITDA vs. Current Valuation
| ALMD Stock | ILA 39.20 5.90 17.72% |
For Allmed Solutions profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Allmed Solutions to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Allmed Solutions utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Allmed Solutions's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Allmed Solutions over time as well as its relative position and ranking within its peers.
Allmed |
Allmed Solutions Current Valuation vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Allmed Solutions's current stock value. Our valuation model uses many indicators to compare Allmed Solutions value to that of its competitors to determine the firm's financial worth. Allmed Solutions is number one stock in ebitda category among its peers. It is rated fourth in current valuation category among its peers reporting about 3.41 of Current Valuation per EBITDA. Comparative valuation analysis is a catch-all model that can be used if you cannot value Allmed Solutions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Allmed Solutions' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Allmed Current Valuation vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Allmed Solutions |
| = | 3.86 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Allmed Solutions |
| = | 13.15 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Allmed Current Valuation vs Competition
Allmed Solutions is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 306.11 Million. Allmed Solutions holds roughly 13.15 Million in current valuation claiming about 4% of equities under Health Care industry.
Allmed Solutions Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Allmed Solutions, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Allmed Solutions will eventually generate negative long term returns. The profitability progress is the general direction of Allmed Solutions' change in net profit over the period of time. It can combine multiple indicators of Allmed Solutions, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Allium Medical Solutions Ltd., a medical device company, develops, manufactures, and markets minimally invasive products in Israel and internationally. Allium Medical Solutions Ltd. is headquartered in Caesarea, Israel. ALLMED SOLUTIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 40 people.
Allmed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Allmed Solutions. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Allmed Solutions position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Allmed Solutions' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Allmed Solutions without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Use Investing Themes to Complement your Allmed Solutions position
In addition to having Allmed Solutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Cap ETFs Thematic Idea Now
Large Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large Cap ETFs theme has 676 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Allmed Stock
To fully project Allmed Solutions' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Allmed Solutions at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Allmed Solutions' income statement, its balance sheet, and the statement of cash flows.